Atlas FDA

ABBOTT AXSYM HBSAG

FDA premarket approval P050049/S002 · decided 2007-12-19

Approval details

PMA number
P050049
Supplement
S002
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
ABBOTT AXSYM HBSAG
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Abbott Laboratories, Inc.
Date received
2007-12-13
Decision date
2007-12-19
Days to decision
6 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
APPROVAL FOR LABELING MODIFICATIONS THAT CLARIFIES THE MEANING OF THE FINAL INTERPRETATION REPEAT REACTIVE, NONCONFORMING FOR HBSAG IN THE AXSYM HBSAG CONFIRMATORY PACKAGE INSERT. ALSO, CHANGES TO THE AXSYM HBSAG PACKAGE INSERT TO ALIGN WITH THE REMOVAL OF THE TERM "REPEAT REACTIVE" FROM THE INTERPRETATION OF RESULTS FOR THE AXSYM HBSAG CONFIRMATORY ASSAYS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ARCHITECT IVALPROIC ACID REAGENTS AND ARCHITECT IVALPROIC ACID CALIBRATORS, MODELS 1P35, 1P35 (K090358)Abbott Laboratories, Inc.2009-08-06
CREATININE (K061193)Abbott Laboratories, Inc.2006-06-23
PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS (K051213)Abbott Laboratories, Inc.2005-05-27
FOX PLUS PTA CATHETER (K040954)Abbott Laboratories, Inc.2004-05-11
AXSYM CYCLOSPORINE (K040761)Abbott Laboratories, Inc.2004-04-30
GEMSTAR INFUSION PUMP SYSTEM, 7 THERAPY, 6 THERAPY & PAIN MANAGEMENT (K023062)Abbott Laboratories, Inc.2002-09-30